CALC
Calcimedica Inc
NASDAQ · Pharmaceuticals
$0.60
-0.01 (-1.77%)
Open$0.59
Previous Close$0.61
Day High$0.66
Day Low$0.58
52W High$43.72
52W Low$16.88
Volume—
Avg Volume592.4K
Market Cap8.65M
P/E Ratio17.59
EPS$1.90
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+6,017.3% upside
Current
$0.60
$0.60
Target
$36.71
$36.71
$29.06
$36.71 avg
$43.55
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.85M | 1.83M | 1.75M |
| Net Income | 558.6K | 478.0K | 437.1K |
| Profit Margin | 30.2% | 26.2% | 25.0% |
| EBITDA | 671.1K | 736.1K | 607.5K |
| Free Cash Flow | 473.4K | 406.9K | 399.5K |
| Rev Growth | +1.8% | +20.8% | +4.5% |
| Debt/Equity | 0.11 | 0.11 | 0.14 |
Dividend
Dividend Yield2.55%
Annual Dividend$0.85
Payout Ratio44.8%
Frequencyquarterly
Ex-DividendMar 31, 2026
Pay DateApr 12, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |